Business units: (1) Enzyme Therapy (Lysoclear, Inc.), (2) Senolytics (FoxBio, Inc.), (3) Small Molecule drug discovery (Antoxerene, Inc.), (4) Antibody Mimetics (Auctus Biologics, Inc.), (5) Protein Chemistry tools (RecombiPure, Inc.), (6) Contract research services (Icaria Life Sciences, Inc.), and (7) A strategic investment fund (Grapeseed.Bio)Lead physical and scientific operations with Ichor's CEO establishing objectives, research trajectory, regulatory path, IP strategy, and participated in fundraising >$15M in equity financing. Co-founded and oversaw contract research projects for 3rd party clients (Icaria life sciences, Inc.). Directly supervised >40 employees. Extensively involved in negotiations and scientific strategy.

Courtesy appointment in the Lewis School of Health Sciences as part of industry/academic collaboration with Clarkson University.

Research Assistant Professor in the Department of Physics in The College of Arts and Sciences at Syracuse University. Ichor Therapeutics and its affiliated companies will work alongside the biophysics programs and with the BioInspired Institute at Syracuse University. This position will allow for the mutual growth between Syracuse University faculty, graduate students, and the Ichor Therapeutics team. This collaboration will stand as a foundation where we hope to build a network of research targeting intrinsically disordered proteins involved in cellular processes and protein trafficking.

Principal Investigator and Steering Committee member for graduate students in Ichor Therapeutics/SUNY ESF collaborative PhD program

I use recombinant protein engineering techniques to create robust biological nanostructures which are employed as novel biosensors for bimolecular detection of diverse analytes.

Founded Finger Lakes Bio, LLC and in-licensed pRexpress, a patent-pending protein production technology that enables scalable manufacturing of difficult and impossible to produce proteins. Raised pre-seed round for early development. Was acquired by Ichor Therapeutics Inc. (2017) and lead to >$15M in equity raised for Auctus Biologics Inc. Antoxerene and FoxBio Inc.

RLH is a private investment company looking to fund early stage medical device companies.

Consulted new students entering the laboratory on single molecule procedures and analysis. Conducted electrophysiology research and kinetic analysis to present in a publication. Worked remotely fielding questions and handling peer-reviewed revisions when applicable.

Designed, managed, and carried out independent research in single molecule Biophysics using BLM electrophysiology, and Protein engineering experiments using IVTT, PCR, and HPLC.Maintained the laboratory, analyzed and interpreted Kinetic data, managed new appointees, wrote and published results.

Planned and conducted lessons once a week to a class for Syracuse High School students.